Advances in Oxidative Stress and Eye Diseases
A special issue of Antioxidants (ISSN 2076-3921). This special issue belongs to the section "Health Outcomes of Antioxidants and Oxidative Stress".
Deadline for manuscript submissions: closed (30 December 2021) | Viewed by 11790
Special Issue Editors
Interests: corneal regeneration; G protein-coupled receptors; inflammation; ocular perfusion; oxidative stress; retinal ischemia; vascular endothelial function
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Reactive oxygen species (ROS) are important signaling molecules that regulate numerous physiological actions, such as neuron function and vascular reactivity. However, excessive ROS levels can modify cellular molecules and impair their function. Moreover, ROS can stimulate the production of inflammatory cytokines, causing inflammation and cell death. Hence, it is not surprising that elevated ROS levels have been observed in various ocular diseases, such as glaucoma, diabetic retinopathy, and age-related macular degeneration (AMD), but also in ocular surface diseases. Different compounds with direct or indirect antioxidant activity have been used to reduce ROS accumulation in animal ocular disease models and humans. We invite submissions that cover the following topics to this Special Issue:
- Studies that provide substantial mechanistic insight into the pathophysiology of ROS in eye diseases in animal models or patients.
- Proof-of-concept studies for certain antioxidant agents demonstrating their influence on oxidative stress and ocular disease onset and/or progression. The studies should employ accepted state-of-the-art techniques to assess oxidative stress and/or inflammation.
Dr. Adrian Gericke
Dr. Verena Prokosch
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antioxidants is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- oxidative stress
- reactive oxygen species (ROS)
- eye
- pathophysiology
- therapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
